Patents by Inventor Cristiana Bruno

Cristiana Bruno has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITIONS IN THE FORM OF GEL CONTAINING XYLOGLUCAN AND ALCOHOLS FOR THE CONTROLLED RELEASE OF ACTIVE INGREDIENTS
    Publication number: 20220241193
    Abstract: The invention relates to gel compositions comprising pharmaceutical active ingredients. The composition comprises xyloglucan at a concentration between 0.1% and 10.0% by total weight of the composition, together with a primary alcohol at a concentration between 20.0 and 50.0% by total weight of the composition. The invention also describes a process for the preparation of the composition and its use in the treatment of pathologies wherein a controlled release of the active principle is useful.
    Type: Application
    Filed: June 11, 2020
    Publication date: August 4, 2022
    Applicant: ALFASIGMA S.P.A.
    Inventors: Giuseppe Claudio Viscomi, Paola MAFFEI, Cristiana Bruno, Mascia Federici, Clelia Dispenza, Maria Antonietta Sabatino
  • Sulodexide for use in the treatment of pathologies wherein metalloproteinases are involved
    Patent number: 8987231
    Abstract: The present invention describes sulodexide or at least one of its components for use in the reduction of circulating matrix metalloproteinase (MMPs), in particular MMP-9. Sulodexide and its composition are useful for the treatment of pathologies wherein the MMPs are involved, such as cardiovascular disease, cardiovascular disease caused by diabetes, varicose veins, chronic venous insufficiency (CVI), gastrointestinal ulcers, pulmonary disease, and neoplastic pathologies.
    Type: Grant
    Filed: April 20, 2011
    Date of Patent: March 24, 2015
    Assignee: Alfa Wassermann S.p.A.
    Inventors: Giuseppe Claudio Viscomi, Ferdinando Mannello, Cristiana Bruno
  • SULODEXIDE FOR USE IN THE TREATMENT OF PATHOLOGIES WHEREIN METALLOPROTEINASES ARE INVOLVED
    Publication number: 20130045946
    Abstract: The present invention describes sulodexide or at least one of its components for use in the reduction of circulating matrix metalloproteinase (MMPs), in particular MMP-9. Sulodexide and its composition are useful for the treatment of pathologies wherein the MMPs are involved, such as cardiovascular disease, cardiovascular disease caused by diabetes, varicose veins, chronic venous insufficiency (CVI), gastrointestinal ulcers, pulmonary disease, and neoplastic pathologies.
    Type: Application
    Filed: April 20, 2011
    Publication date: February 21, 2013
    Inventors: Giuseppe Claudio Viscomi, Ferdinando Mannello, Cristiana Bruno